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Introduction
Adolescence is a key period with regard to substance
use. The risk of substance-use onset is highest in this
age group [18]. The earlier the onset of substance use,
the greater the risk of future dependence [17]. Fur-
thermore, substance use in adolescents may lead to
impairments that will interfere with normal develop-
ment, which might, in turn, reinforce substance use
[7, 12, 17, 21]. Although the association between
substance-use disorders and depression has been
consistently established, little evidence regarding the
underlying mechanisms behind this association is
currently available [9–11, 23]. The present study sets
out to explore the concurrent natural course of sub-
stance use and depressive state in a community-based
sample of regular adolescent substance users.
As in other European countries, substance-use
trends in Switzerland show a disturbing increase in
teenagers. In 2002, lifetime cannabis use was 49.9% in
boys and 39.1% in girls aged 15–16 years, which
represents a 20% increase since 1994. Daily cannabis
use is also increasing, with 6.5% of adolescents
reporting daily use in recent years [16]. Moreover,
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j Abstract Objective To examine
the relation between depression
and substance use in adolescents
and the concomitant courses of
both disorders. Methods Four
individual interviews were admin-
istered to 85 adolescent substance
users aged 14–19 years (mean
17.1 years, SD 1.4) over a 3.5 year
period using the Adolescent Drug
Abuse Interview (ADAD) and the
Beck Depression Inventory (BDI-
13). Results No predictive effect
was observed on one dimension
over the other, but each dimension
was predictive of its own course. A
decrease in substance-use severity
paralleled a decrease in depressive
state. Similarly, stable substance-
use rates, either at a low or a high
level, tended to be associated with
low or high levels of depression,
respectively. However, an increase
in substance use was not accom-
panied by an increase in depres-
sive states. Moreover, depression
varied greatly between adoles-
cents, and according to gender
and age. Conclusions Depressive
states and substance use in ado-
lescents can vary considerably
overtime, and are closely but
rather synchronically related.
Since most of the adolescents do
not seek help for substance-related
problems, substance use should be
systematically assessed in adoles-
cents presenting with a depressive
state.
j Key words adolescent – sub-
stance use – depression – longi-
tudinal design – community study
ORIGINAL CONTRIBUTION







L. Chinet, MA (&) Æ B. Plancherel
M. Bolognini Æ M. Bernard Æ J. Laget
G. Daniele Æ O. Halfon
SUPEA Research Unit








frequent, risky behaviours such as binge drinking,
daily cannabis use, and multiple substance use on the
same occasion [15, 16, 24].
Both community-based and clinical studies show
the large co-morbidity between substance-use disor-
ders and other psychiatric disorders, especially anxi-
ety and depression, in adult as well as adolescent
populations [2, 5, 18–20]. Prevalence rates of
depression of between 20 and 30% are reported in
adolescent substance users [2].
Four models have been proposed to explain the
relation between substance use and psychiatric dis-
orders [23]. The first model asserts that high rates of
co-morbidity are the result of shared underlying fac-
tors, such as genetic factors or personality disorders,
inducing common vulnerability. The second model
postulates that substance use is secondary to psychi-
atric disorders, and notably that substance use could
be a way of alleviating feeling bad’ (i.e. affect regu-
lation model). In contrast, the third model posits that
psychiatric illness is induced by primary substance
use. Finally, the fourth model asserts that interacting
effects accounting for the increased co-morbidity
rates could link both disorders.
The objective of this study was to investigate the
relation between depression and substance use in
adolescents and the concomitant courses of both
disorders. In particular, the study sets out to examine
the hypotheses referring to the common factor model,
the affect regulation model, the secondary psychiatric
disorder model and the bi-directional model.
Methods
j Population
The sample at baseline included 102 adolescents (66
boys and 36 girls aged 14–19 years, 17.1 years SD 1.4)
recruited between January 1999 and March 2000 in
the French-speaking part of Switzerland, an area with
approximately one million inhabitants. They all fitted
the criterion of regular illicit drug or alcohol use (at
least one substance once a week during the last
3 months) at the first interview (time 1). All of them
were regular cannabis users. Ninety-four per cent
fitted the DSM-IV (Diagnostic and Statistical Manual
of Mental Disorders version 4) criteria for cannabis
abuse or dependence, of which 54% received addi-
tional substance-abuse diagnoses, mainly for alcohol
(38%). Seventy-five percent were Swiss and 25% came
from another country (mainly European), which
corresponds to the percentages observed in the gen-
eral population. Eighty-nine percent of the subjects
were native French speakers. None of the subjects was
excluded due to language difficulties or because of
psychosis or chronic physical disease, which were
exclusion criteria. Regarding family background, 63%
of the subjects had lived most of their life with both
parents whereas 16% had lived mainly with their
mother alone. The remaining 21% had lived either in
a mixed family (11%); with adoptive parents, other
relatives, or a foster family (6%); or in community
homes (4%). They were recruited in outpatient units
(26%), residential units (27%), hospitals (15%) and
leisure places (32%).
j Procedure
Adolescents were recruited in a variety of contexts,
through collaboration with youth-service profession-
als, through dissemination and direct distribution of
flyers in public and leisure places, or through direct
contact. They were informed about the conditions of
participation before they joined the study, in partic-
ular the fact that they were free to leave the study at
any time. They were given a SFr. 50.00 incentive for
the time spent on each interview. They all gave writ-
ten consent and Ethical Committee approval was
obtained. Three consecutive interviews, hereafter re-
ferred to as time 2, time 3 and time 4, were admin-
istered after 9, 18 and 42 months. Drop-out rates were
17% at time 3 and 19% at time 4. Most of the drop-
outs were due to loss of contact because of moving or
telephone number changes. Three adolescents left the
study on their own. The time 3 and time 4 samples
were comparable to the baseline sample according to
age (F [1,100] = 1.728, P = 0.192 and F [1,100] =
0.002, P = 0.961, respectively), gender (v2 = 0.4,
P2 = 0.1, P = 0.74, respectively) and sociodemo-
graphic characteristics.
At each time, trained psychologists administered a
standard protocol to adolescents individually.
Depression was measured using the BDI-13 (Beck
Depression Inventory, short version) [3]. The French
translation was used [8], which assesses the current
depressive state. This instrument is composed of 13
questions with four statements related to depression
symptomatology rated on Likert-type scales from 0 to
3 with the total score ranging from 0 to 39. Total
scores ranging from 0 to 4 correspond to ‘‘not de-
pressed’’, those from 5 to 7 to ‘‘lighty depressed’’,
those from 8 to 15 to ‘‘fairly depressed’’ and those of
16 and over to ‘‘severely depressed’’. In this study, the
total score was used in order to study depressive state
changes over time compared to substance-use evolu-
tion. The French version of the ADAD (Adolescent
Drug Abuse Diagnosis) [4] was used to evaluate illegal
drug and alcohol use and associated life problem
areas. For each domain, interviewers attribute sever-
ity-rating scores ranging from 0 (no real problem) to
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9 (extreme problem, treatment absolutely necessary)
on the basis of the adolescents’ reports and self-per-
ception of their situation. A severity rating score of 4
and over indicates that the problems in this area are
important and necessitate treatment. Finally the MINI
(Mini International Neuropsychiatric Interview) [25]
was used, which provides substance-abuse diagnoses
based on DSM-IV criteria.
j Data transformation
Three transformations were performed before analyz-
ing the data. First, BDI mean scores showed a high
variability with irregular variations across gender and
substance-use evolution subgroups (SUES; see Table 1
in the Results). Therefore BDI individual scores were
transformed into natural logarithm scores (hereafter
mentioned as BDI ln mean scores), and scores equal to
zero were replaced manually. The transformation to
BDI ln mean scores made the variation smaller and
more constant across levels of data series. BDI ln scores
were thus used in the subsequent statistical analyses.
Second, age was dichotomised into adolescents aged
under 17 years and those aged 17 and over to introduce
this variable into the general linear model (GLM)
analyses as a between-subjects factor. The younger and
older age groups contained 46 and 39 adolescents,
respectively. Finally, the grouping analysis of Wills
et al. [27] was used to explore the courses of both
depression and substance use simultaneously over time
according to gender and age. Therefore, clustering
analysis using individual substance-use severity scores
at times 1, 2 and 3 was performed to determine
empirical patterns of substance-use over time. The
depression rate of drop-outs at baseline was signifi-
cantly higher compared to those who completed the
time 4 interview. Moreover, subjects’ age at time 4
ranging from 18- to 23-years old made them more
comparable to young adults than adolescents, and the
time frame between time 4 and time 3 differed from the
others. For these reasons, the clustering analysis was
conducted on the 85 adolescents who completed the
first three interviews. The analysis produced four SUES:
one group of 15 adolescents, referred to as increasers
(IC), whose substance use increased over time; one
group of 22 adolescents, referred to as decreasers (DC),
whose substance use decreased over time; and two
groups with either low or high stable substance-use
severity, one group of 18 low persisters (LP) and one
composed of 30 high persisters (HP). Cluster mem-
bership was cross-validated by making sure that in-
creasers’ and decreasers’ substance-use score changes
were of 2 points or more. These substance-use evolu-
tion patterns were confirmed by substance-use trends
in each SUES at time 4, with IC and HP presenting
significantly higher substance-use severity scores than
DC and LP (F [3,74] = 6.98, P = 0.000).
Table 1 Depression and substance-use mean scores according to substance-use evolution subgroups (SUES), gender and age
BDI mean scores* ADAD drug severity mean scores
time 1 time 2 time 3 Mean time 1 time 2 time 3 Mean
SUES
Increasers (n = 15) Mean 7.53 9.10 8.47 8.37 4.47 5.73 6.93 5.71
SD 5.04 6.82 6.10 5.11 1.51 1.03 0.96 0.93
Decreasers (n = 22) Mean 9.05 6.11 3.86 6.28 6.23 4.50 2.55 4.42
SD 5.18 4.85 4.23 3.89 1.60 2.54 1.34 1.49
Low persisters (n = 18) Mean 6.06 5.00 4.78 5.28 3.67 3.39 3.33 3.46
SD 6.99 7.88 6.98 6.59 1.61 1.75 1.68 1.60
High persisters (n = 30) Mean 10.30 8.31 8.62 9.12 6.87 5.86 6.77 6.47
SD 7.96 6.88 7.91 6.52 1.07 1.43 1.07 1.15
Gender
Girls (n = 30) Mean 10.80 8.97 7.29 9.01 5.90 4.76 4.73 5.18
SD 8.13 9.19 7.54 7.50 2.34 2.32 2.57 2.14
Boys (n = 55) Mean 7.38 6.24 6.15 6.56 5.44 5.05 5.11 5.16
SD 5.56 4.67 6.48 4.54 1.63 1.87 2.23 1.53
Age
Youngers (n = 46) Mean 7.15 6.15 5.47 6.22 5.28 5.04 4.83 5.05
SD 5.65 5.39 5.11 4.26 1.60 1.76 2.17 1.35
Olders (n = 39) Mean 10.28 8.42 7.82 8.87 5.97 4.84 5.15 5.31
SD 7.56 7.86 8.35 7.07 2.18 2.33 2.56 2.15
Total (n = 85) Mean 8.59 7.20 6.55 7.44 5.60 4.95 4.98 5.17
SD 6.74 6.70 6.85 5.84 1.91 2.03 2.35 1.76
*BDI mean scores ranging from 0 to 4 correspond to ‘‘not depressed’’, from 5 to 8 to ‘‘lightly depressed’’, from 9 to 15 to ‘‘fairly depressed’’ and 16 and over to
‘‘severely depressed’’
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j Statistical analyses
Preliminary analyses are presented that explore
depression, substance use and individual factors such
as gender, age and substance-use duration. Structural
equation modeling, using Amos software [1], was
then performed to investigate predictive relations
between depression and substance use. Finally, GLM
with repeated measures were performed using BDI ln
mean scores at each time measure as the dependent
variable and SUES, age groups and gender as factors.
These analyses allowed the appraisal of the joint
evolution of both dimensions.
Results
Table 1 presents BDI and ADAD substance-use
severity rating mean scores according to SUES, gen-
der and age at time 1, 2 and 3.
Drug severity rating total mean scores were rela-
tively high, indicating a need for some treatment,
except in the LP group. Older adolescents tended to
be rated slightly higher than younger adolescents for
drug severity, but only at baseline (F [1,83] = 2.83,
P = 0.096). There was no difference in drug severity
according to gender. Concerning depression, BDI
total mean scores showed an overall moderate
depressive state (between lightly and fairly depressed
according to BDI scores grouping). Depressive rates
differed at baseline according to gender, girls being
significantly more depressed than boys (F [1,83] =
5.25, P = 0.024). However, this discrepancy dimin-
ished over time and was not found in BDI total
mean scores. With respect to age groups, older
adolescents tended to be globally more depressed
than the younger adolescents (F [1,83] = 3.54,
P = 0.063), which was especially the result of
depression rates at baseline (2.00 SD 0.94 and 1.64
SD 0.89, respectively). SUES were then compared
according to potential influential factors. Substance-
use duration varied according to SUES (F
[3,81] = 2.58, P = 0.059). HP had been using sub-
stances since a longer period of time compared to LP
(2.8 years, SD 1.4 and 2.1 years SD 0.93, respec-
tively). However no difference appeared among
SUES according to age.
Structural equation modeling was then performed
to investigate predictive relations between depression
and substance use. Auto-regressive cross-lagged panel
models were performed with BDI ln and substance-
use severity rating mean scores at each time point.
According to the alternative hypotheses presented in
the introduction, two a priori models were tested, one
with cross-lagged inter-dimensional paths linking
prior substance use with successive depres-
sion—corresponding to the secondary mood disor-
der model’—and one with paths between prior
depression and substance use—according to the af-
fect regulation model’. Both models failed to meet the
criteria for adequate fit. However, when both models
were combined and 2-lag intra-dimensional paths
were added, all criteria indicated a good model fit
(c2 = 11.97, df 8, P = 0.153, RMSEA 0.07).
Fig. 1 presents this model comprising 1- and 2-lag
intra-dimensional paths and 1-lag inter-dimensional
paths, showing that both depressive state and sub-
stance use were significantly predictive of each future
respective course. Globally direct effects within each
dimension predominated compared to cross-lagged
inter-dimensional path coefficients. Inter-dimen-
sional path coefficients were, overall, relatively low,
except for one negative coefficient between substance
use at time 2 and depression at time 3. Simple linear
regression showed, however, that the residual part of
substance use 2 in predicting BDI ln 3 was near zero
once BDI ln 2 was controlled for. Finally, coefficients
were moderately high between both dimensions
within the same time measure.
GLM with repeated measures were performed
using time 1 to time 3 BDI ln mean scores as
dependent variables and SUES, age groups and gender
as factors. These analyses allowed appraisal of the
joint evolution of both dimensions.
A time effect appeared in the GLM analysis
(F [2,134] = 4.64, P = 0.011), which indicated that the
depressive state tended to decrease over time (see
Fig. 2). There was a tendency towards differentiated
evolution patterns for depression according to sub-
stance-use subgroups (F [6,134] = 1.94, P = 0.079).
The depressive state decreased dramatically in the DC
group whereas it remained stable at a high level in the
HP and IC groups, and at a low level in the LP group.
Two significant effects appeared in triple interactions
Fig. 1 Effects of prior depression (BDI ln mean scores) and substance-use
severity (ADAD mean scores) on successive measures. One-tailed arrows are
path-coefficients and the two-tailed is a correlation
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with time, SUES and gender (F [6,134] = 2.70,
P = 0.017), and with time, gender and age
(F [1,67] = 5.61, P = 0.021). Older girls presented with
higher depressive states at baseline, which then tended
to show a greater decrease over time compared to the
other adolescents. Three between-subjects effects oc-
curred, two tendencies with SUES (F [3,67] = 2.49,
P = 0.068) and gender (F [1,67] = 3.60, P = 0.062),
and one significant effect with age (F [1,67] = 5.90,
P = 0.018). Girls and older subjects appeared to be
more depressed than boys and younger subjects,
respectively. Furthermore, there was an interaction of
gender with age (F [1,67] = 4.19, P = 0.045), older
girls being more depressed than all other adolescents.
Regarding the difference in depression total mean
scores over time according to SUES, post-hoc tests
performed in the one-way analysis comparing BDI
total mean scores by subgroups showed a significant
difference between the LP and HP groups, the former
being globally less depressed than the latter (see Ta-
ble 1). At time 4, the depressive state in the LP group
remained significantly lower than that in the HP
group, and was also significantly lower than those in
the IC and DC groups (1.15 SD 0.99, 6.62 SD 5.13, 7.30
SD 5.12 and 5.70 SD 4.39, respectively, F [3,65] = 5.29,
P = 0.003).
Discussion
The different patterns evidenced overtime show that
depression and substance use may vary considerably
during adolescence. Regarding changes over time in
depression and substance use, there was no predictive
relation of one dimension over the other. Instead,
prior depressive states and substance-use severity
were each predictive of successive measures in the
respective dimensions. Moreover, when analysing the
substance-use evolution subgroups separately,
depression varied over time according to substance-
use evolution patterns, gender and age. In every case,
a decrease in substance-use severity paralleled a de-
crease in depressive state. In the same way, stable
substance-use subgroups, either with a low or a high
level of substance-use severity, tended to present
stable low or high levels of depression, respectively.
An increase in substance use was not accompanied by
an increased depressive state, which can be explained
by relatively high depressive states at baseline. The
lack of prediction of one dimension over the other
argues against both secondary psychiatric disor-
der—and affect regulation explanation models [23].
Whereas the common factor model cannot be defi-
nitely proved false by our results, they give more
support to the interacting effects model.
Globally depressive state differed according to
gender and age, girls—especially older girls—being
significantly more depressed than boys. However,
depression rates were rather heterogeneous and var-
ied over time, particularly in those groups where
depression was highest at baseline. These results
paralleled those found in the literature [6, 10, 11, 28].
Substance misuse was associated with relatively
high depressive states. Moreover girls, and especially
older ones, presented more severe, but highly heter-
ogeneous, depressive states.
There were no predictive relations for one dimen-
sion over the other. Prior depression rates predicted
successive depression rates, which was also the case
for substance-use severity. Moreover, depressive states
and substance-use severity were moderately associ-
ated at each time point. The importance of these
relations, on the one hand within each dimension
across time and on the other hand in cross-dimen-
sional paths at each time point, could induce an
artefact accounting for the negative coefficients found
in two of the cross-lagged paths. This explanation is
supported by the lack of a singular’ predictive residual
part of substance-use once prior depression is con-
trolled for.
Depression course was then analysed according to
substance-use evolution patterns, gender and age. A
general observation was that a decrease in substance-
use severity was accompanied by a decrease in
depressive symptoms. Moreover, adolescents whose
substance-use remained stable either at a low (LP) or
a high (HP) level tended to present similarly low and
high depressive rates. Depressive states and substance
Fig. 2 BDI mean scores at time 1, 2 and 3 by substance-use evolution
subgroups (SUES)
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use in adolescents appear to be closely, but rather
synchronically, related. This could be explained by
the fact that each problem, and its associated
impairments, might contribute to reinforce the other
in a reciprocal way. These observations are consistent
with those of Kandel et al. [19]; they support the
usefulness of detecting substance misuse and
depressive states at an early stage to provide adoles-
cents with an integrated-treatment plan that will tar-
get both disorders and help prevent mutual relapse
[13, 14].
Some limitations should be mentioned regarding
the results discussed here. First, depression rates
showed an important variability, with some adoles-
cents having extremely high scores, especially at
baseline where one-third of the sample was recruited
from within health or social services. This could ex-
plain the general tendency towards a decrease in
depression rates (regression toward the mean), and
the fact that an increase in substance use was not
accompanied by an increase in depressive state. Sec-
ond, the respective courses of depression and sub-
stance use were evaluated when substance use was
already established. Thus depressive traits might be
present prior to substance-use onset and vice versa.
Third, the intervals between each time measure were
large. Consequently, it might be the case that a causal
relation exists between the courses of both disorders,
but within a shorter timescale.
Nevertheless these results show that some of the
depressive symptoms could be directly associated
with substance-use severity, especially in boys [28].
Regarding the treatment of depressive states in ado-
lescents, this observation stresses the importance of
carefully assessing substance use and taking it into
account in the treatment planning. Moreover, current
pharmacological treatments for adolescent depression
were not found to be particularly effective, notably in
substance-user adolescents [22], and a 6–8 week
period was required before any effect was seen [26].
Further research is needed to follow both disorder
courses with shorter time intervals between each
measure in order to explore in-depth an eventual
causal relation.
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